Introduction
Apoptosis plays an important role in a variety of biological events, including morphogenesis, maintenance of tissue homeostasis, and removal of harmful cells (reviewed by Arends and Wyllie, 1991) . Apoptotic signal transduction pathways activated by various stimuli converge into a phylogenically conserved common pathway, which is driven by caspases and regulated by the Bcl-2 family (reviewed by Salvesen and Dixit, 1997; Thornberry and Lazebnik, 1998) . Caspases are activated by proteolytic cleavage of their proforms, and then cleave various cellular substrates (reviewed by Salvesen and Dixit, 1997; Thornberry and Lazebnik, 1998) .
The Bcl-2 family is characterized by the conservation of Bcl-2 homology (BH) domains (reviewed by Adams and Cory, 1998; Tsujimoto, 1998) , and it consists of pro-apoptotic molecules (i.e. Bax, Bak, Bik, Bad, Bim and Bid) and anti-apoptotic molecules (i.e. Bcl-2, Bclx L , and Bcl-w) (reviewed by Adams and Cory, 1998; Tsujimoto, 1998) . Recent studies have focused on their eects on the mitochondria, which play an essential role in apoptotic signal transduction (reviewed by Green and Reed, 1998; Tsujimoto and Shimizu, 2000) . Various apoptotic stimuli have been shown to induce mitochondrial changes that result in the release of apoptogenic factors like mitochondrial cytochrome c (Liu et al., 1996) into the cytoplasm, which leads to activation of caspase-9 through Apaf-1 (Zou et al., 1997; Li et al., 1997) . The release of cytochrome c is prevented by anti-apoptotic Bcl-2 family members (Yang et al., 1997; Kluck et al., 1997) . Several eects of them on the mitochondria have been proposed, such as closure of the voltage-dependent anion channel (VDAC) (Shimizu et al., 1999) , the adenine nucleotide translocator (Marzo et al., 1998) or the permeability transition pore (Zamzami et al., 1996; Narita et al., 1998) , as well as the binding and sequestration of Apaf-1 (Pan et al., 1998; Hu et al., 1998) .
Although the eects of Bcl-2 on the mitochondria have been studied intensively, little is known about the eects of Bcl-2 on the endoplasmic reticulum (ER), where anti-apoptotic Bcl-2 family proteins are also localized. Bcl-x L and Bcl-2 regulate the release of calcium from intracellular stores, which are primarily located in the ER (Bay et al., 1993; Lam et al., 1994; He et al., 1997) . It was also reported that Bcl-2 targeted to the ER can inhibit Myc-induced apoptosis (Zhu et al., 1996) . These results suggest that Bcl-2 located on the ER might act to prevent apoptosis, although the mechanisms involved are not clearly understood.
Bcl-x L and/or Bcl-2 are known to interact with various proteins, such as pro-apoptotic Bcl-2 family members and other proteins from outside the Bcl-2 family. Among them, SMN (Iwahashi et al., 1997) , Bis (Lee et al., 1999) , and BAG-1 (Takayama et al., 1995) are reported to enhance the anti-apoptotic eect of Bcl-2. Bap31 (Ng et al., 1997) , and SERCA (Kuo et al., 1998) are localized on the ER, but their eects on the activity of Bcl-x L or Bcl-2 remain unknown.
The reticulon family gene 1 (RTN1) was identi®ed by antibodies that stained a subset of neuroendocrine tissues and neoplasms (Roebroek et al., 1993) , and was formerly called neuroendocrine-speci®c protein (NSP) gene. RTN1 produces three splice variants, which are designated NSP-A, -B, and -C. On the other hand, expression of its family genes, RTN2 and RTN3 is almost ubiquitous (Roebroek et al., 1998; Moreira et al., 1999) .
Immunohistochemical studies have revealed that RTN proteins are anchored to the ER (Senden et al., 1996; GrandPre et al., 2000) probably through two putative transmembrane domains in the homologous C-terminal region, so these proteins were renamed the reticulon (RTN) family (Roebroek et al., 1998) . Little is known about the function of the RTN family in apoptosis.
Here we describe two Bcl-x L -interacting proteins belonging to the RTN family, NSP-C and a novel member that we have termed RTN-x S . Unlike NSP-C, RTN-x S can also interact with Bcl-2. RTN-x S reduced the anti-apoptotic activity of both Bcl-x L and Bcl-2, while NSP-C only reduced that of Bcl-x L . Change in subcellular localization of Bcl-2 family proteins from the mitochondria to the ER was thought to be involved in both cases.
Results

Identification of RTN-x S
To search for proteins interacting with Bcl-x L , we screened human fetal and adult brain libraries using the yeast two-hybrid system, with full-length human Bcl-x L as the bait. Fifty-seven b-galactosidase-positive clones were obtained from 2610 7 transformants, and were found to contain 19 bad, seven bax, three Bnip3L, and one bid gene, as well as 27 non-bcl-2 family clones. Among the 27 clones, one clone carried the entire coding sequence of NSP-C (RTN1-C) (Roebroek et al., 1993) and two clones (4-20s and 15-97) corresponded to a new member of the RTN family, which was designated RTN-x. Analysis using the yeast two-hybrid system revealed that both 4-20s and NSP-C bound to Bcl-x L , but only 4-20s bound to Bcl-2 (Table 1) .
We obtained the full-length cDNA sequence of RTN-x as described in Materials and methods. There were two kinds of cDNA, which may have been produced by alternative splicing. The longer cDNA, which we termed RTN-x L , contained 3576 bp encoding 1192 amino acid residues, and was identical to the human cDNA clone KIAA0886 in the DNA data base (Nagase et al., 1998) . The shorter form, termed RTNx S , consisted of 1119 bp encoding 373 amino acid residues, and lacked residues 186 to 1004 of RTN-x L ( Figure 1a ). The C-terminal amino acid sequence of RTN-x S (aa 188 ± 373) shared 69% identity with that of NSP-C (Figure 1b) , and was the region where RTN family proteins showed signi®cant homology with each other (Roebroek et al., 1993 (Roebroek et al., , 1998 Moreira et al., 1999) . RTN-x L and RTN-x S contained two putative transmembrane domains, as do other RTN family proteins ( Figure 1b and Roebroek et al., 1993 Roebroek et al., , 1998 Moreira et al., 1999) .
Northern blot analysis revealed that the longest transcript (about 5.4 kb) was speci®cally expressed in brain and testis, as well as at low levels in heart and skeletal muscle (Figure 2) , consistent with RTN-x L being isolated from the brain library. A transcript of about 3 kb should correspond to RTN-x S , because RTN-x S is 2457 bp shorter than RTN-x L . RTN-x S was expressed in all tissues examined, except for the liver (Figure 2 ). At least two other transcripts were observed in some tissues, but we did not characterize them. Northern blotting using NSP-C as a probe yielded signals with dierent sizes from those obtained using the RTN-x probe (data not shown).
RTN-x S interacts with both Bcl-x L and Bcl-2 in mammalian cells
To examine the interaction of RTN-x L , RTN-x S , and NSP-C with Bcl-x L or Bcl-2 in mammalian cells, Nterminal HA-tagged RTN-x L , RTN-x S , and NSP-C expression plasmids were constructed (pCAGGS-HA-RTN-x L , pCAGGS-HA-RTN-x S , and pCAGGS-HA-NSP-C, respectively). We transiently co-transfected COS-7 cells with these plasmids together with pCAGGS-Bcl-x L , pCAGGS-Bcl-2, or a control empty vector. Western blot analysis of immune complexes recovered with anti-HA serum revealed that both Bclx L and Bcl-2 were co-immunoprecipitated with HA-RTN-x S only when co-expressed with HA-RTN-x S (Figure 3a,b) . Identical results were obtained when D98/AH2 cells were used instead of COS-7 cells (data not shown). In addition, an anti-Bcl-x L polyclonal antibody (pAb) and an anti-Bcl-2 pAb immunoprecipitated HA-RTN-x S when co-expressed with Bcl-x L and Bcl-2, respectively (data not shown). These results indicated that RTN-x S bound to both Bcl-x L and Bcl-2 in mammalian cells, consistent with the outcome of the yeast two-hybrid experiments (Table 1) . No interaction of RTN-x L with Bcl-x L or Bcl-2 could be detected (data not shown), probably because of its lower level of expression or the eect of its large N-terminal region.
Interaction of RTN-x S with truncated Bcl-x L and Bcl-2, which lack the C-terminal membrane-anchoring domain (37 and 13 amino acid residues, respectively), was also detected by the same methods, but was somewhat weaker (data not shown), suggesting that the interaction of RTN-x S with Bcl-x L or Bcl-2 was not mediated through their C-terminal hydrophobic regions.
We also tested whether endogenous RTN-X S could associate with endogenous Bcl-x L and Bcl-2, using Jurkat cells treated with a protein cross linker; DTBP as described in Materials and methods. As shown in Figure 3c ,d, both the anti-Bcl-x L monoclonal antibody (mAb) and anti-Bcl-2 mAb immunoprecipitated endogenous RTN-x S , indicating that endogenous RTN-x S 
The L40 reporter yeast strain was cotransfected with the indicated plasmids. Individual transfectants were plated in SD/-Trp/-Leu/-His medium and grown for 4 days after which b-galactosidase activity was assayed. The bad gene construct isolated in this study was used as a positive control of Bcl-x L -and Bcl-2-binding protein, while RAD51 was used as a negative control. Symbols represent the time required for development of a strong blue color: +++, less than 1 h; ++, 1 ± 2 h; +, 2 ± 4 h; 7, more than 8 h or not grown on the SD plates
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Translocation of Bcl-x L and Bcl-2 to ER by RTN-x S S Tagami et al 5737 could associate with endogenous Bcl-x L and Bcl-2 in mammalian cells. When HA-NSP-C was used instead of HA-RTN-x S , Bcl-x L but not Bcl-2 was coimmunoprecipitated with HA-NSP-C (Figure 3a ,b). Bcl-2 was not detected even after longer exposure (data not shown). Consistently, an anti-Bcl-x L pAb immunoprecipitated HA-NSP-C, while an anti-Bcl-2 pAb did not (data not shown). These results indicated that HA-NSP-C interacted with Bcl-x L , but not with Bcl-2, which was also consistent with the ®ndings obtained using the yeast two-hybrid system. From these observations, we concluded that RTN-x S interacted with both Bcl-x L and Bcl-2, while NSP-C interacted with Bcl-x L but not with Bcl-2.
RTN-x S is mainly localized on the ER
Because reticulon family members including NSP-C are known to be localized on the ER (Senden et al., 1996; GrandPre et al., 2000) , the subcellular localization of RTN-x S was examined by the two dierent methods; biochemical fractionation and immunocytochemistry. When transiently transfected D98/AH2 cells were biochemically fractionated, both RTN-x S and NSP-C were mainly recovered in the microsomal fraction, with (Figure 5a ), similarly to the previous immunohistochemical studies on reticulons including NSP-C (Senden et al., 1996; GrandPre et al., 2000) . These results indicate that RTN-x S is mainly localized to the ER. The results together with the sequence homology between RTN-x S and NSP-C (Figure 1b ), revealed that RTN-x S is a member of reticulon family. Bcl-2 was mainly localized in the mitochondriaenriched fraction and the nuclear envelope, with a small amount in the microsomal fractions (Figure 4c ), as reported previously (Krajewski et al., 1993; Akao et al., 1994) . On the other hand, Bcl-x L was predominantly recovered in the cytoplasmic fraction under our fractionation conditions ( Figure 4d ). However, immunocytochemical study showed that a majority of Bcl-x L was localized on the mitochondria or peripheral to the mitochondria (Figure 5b ), consistent with the previous observation (Gonzalez et al., 1994) . The discrepancy in the results of biochemical fractionation and immunocytochemistry of Bcl-x L subcellular localization was also observed in previous studies (Hsu et al., 1997; Jia et al., 1999; Hausmann et al., 2000) , and was probably due to loose association of Bcl-x L to the mitochondria and other membranes.
When treated with 0.5% NP40, which strips o the nuclear envelope, the nuclear fraction lost virtually all RTN-x S protein (Figure 4a Since the predominant subcellular localization of RTNx S diers from that of Bcl-x L or Bcl-2 (Figure 4) , we examined whether the subcellular localization of Bcl-x L and Bcl-2 was altered by RTN-x S or not. D98/AH2 cells stably expressing Bcl-x L or Bcl-2 were transiently transfected with RTN-x S , NSP-C, or empty vector, followed by fractionation and Western blotting. The quality of each fractionation procedure was veri®ed by the detection of known compartment-speci®c proteins, including VDAC as a mitochondrial protein and presenilin-1 as an ER protein. Although VDAC was detected in the crude nuclear fraction, this was due to the presence of partially broken cells and/or mitochondria. However, there was no contamination of the mitochondria-enriched fraction by the microsomeenriched fraction, and vice versa (Figure 6a ,b,c, 3rd and 4th panels). Bcl-x L recovered in the microsomal fraction greatly increased from 15+5 to 50+4 and 32+3% when cells were transfected with RTN-x S or NSP-C, respectively (Figure 6a ,b,c, top panels), suggesting translocation of Bcl-x L to the microsomal fraction. Similar change in subcellular localization of Bcl-2 proteins from the mitochondria-enriched fraction to the microsomal fraction was observed when RTN-x S was transfected (Figure 6b, 2nd panel) . When cells were transfected with NSP-C, which did not interact with Bcl-2 (Figure 3b ), the translocation of Bcl-2 was not observed (Figure 6c, 2nd To con®rm that subcellular localization of Bcl-x L is changed from the mitochondria to the ER when RTNx S is expressed, immunocytochemical studies were performed. When COS-7 cells were transfected with Bcl-x L alone, an antibody speci®c to Bcl-x L predominantly stained the mitochondria (Figure 5b) , and only to a lesser extent the ER (Figure 5d ). When cells were cotransfected with Bcl-x L and RTN-x S , immunostaining of Bcl-x L showed a lesser degree of overlap with Mito Tracker (Figure 5c ) and a greater degree of overlap with Bip (Figure 5e ). When NSP-C was used instead of RTN-x S , similar results were observed (data not shown). Transfection with Bcl-2 and RTN-x S showed the similar change in staining pattern of Bcl-2, while transfection with NSP-C did not alter the staining pattern of Bcl-2 (data not shown). Together with the results of subcellular fractionation, these ®ndings suggested that Bcl-x L and Bcl-2 partly changed their subcellular localization to the ER, by binding with RTN-x S or NSP-C.
RTN-x S reduces the anti-apoptotic activity of Bcl-x L and Bcl-2
We next examined the eect of RTN-x S or NSP-C on the preventive activity of Bcl-x L and Bcl-2 against apoptosis induced by tunicamycin (TM) and stauros- Translocation of Bcl-x L and Bcl-2 to ER by RTN-x S S Tagami et al porine (STS). TM is a speci®c inhibitor of Nglycosylation in the ER, and thus causes ER stress, while STS is a wide-range kinase inhibitor. When stable vector transfectants of D98/AH2 cells were transiently transfected with the empty vector, about 70% of the cells underwent apoptosis after 48 h of exposure to ER stress by treatment with TM ( Figure  7a,b) . Apoptosis was reduced to about 11% in D98/ AH2 cells overexpressing Bcl-x L or Bcl-2 (Figure 7a,b) . When these cells were transiently transfected with the pCAGGS-RTN-x S , apoptosis increased to about 45% (Figure 7a,b) . Similar results were obtained when NSP-C was introduced into D98/AH2 cells overexpressing Bcl-x L but not D98/AH2 cells overexpressing Bcl-2 (Figure 7a,b) . Because NSP-C sensitized the vector transfectants of D98/AH2 cells to TM to a similar extent as RTN-x S (Figure 7a ,b, closed diamonds and triangles), prevention of the anti-apoptotic activity of Bcl-x L and Bcl-2 by RTN family proteins was not due to the additive eect of the treatment and/or their transfection. Furthermore, RTN-x S and NSP-C did not aect the levels of Bcl-2 and Bcl-x L (Figure 3a ,b, and data not shown). These results indicated the RTN-x S decreased the anti-apoptotic activity of both Bcl-x L and Bcl-2, while NSP-C only reduced that of Bcl-x L in response to ER stress.
To examine whether the binding-dependent reduction of the anti-apoptotic activity of Bcl-x L and Bcl-2 by RTN-x S and NSP-C also occurred with other apoptotic stimuli, similar experiments were performed using apoptosis induced by STS. Like TM-induced apoptosis, the ability of Bcl-x L to prevent apoptosis by STS was reduced by RTN-x S and NSP-C, although the eect was weaker (Figure 7c) . Similarly, the antiapoptotic activity of Bcl-2 against STS was reduced by RTN-x S , but not by NSP-C (Figure 7d) . Therefore, inhibition of the anti-apoptotic activity of Bcl-x L and Bcl-2 by RTN family members was not restricted to ER stress-induced apoptosis.
From these results, we concluded that RTN-x S and NSP-C reduced the anti-apoptotic activity of Bcl-x L and Bcl-2 by speci®c binding, with one of the mechanisms involving the sequestration of Bcl-x L and Bcl-2 from the mitochondria by RTN family proteins.
Discussion
In the present study, we showed that a novel member of the RTN family, RTN-x S , interacted with both Bcl-x L and Bcl-2, while another family member, NSP-C, only interacted with Bcl-x L in mammalian cells as well as in the yeast two-hybrid system. Binding with RTN-x S or NSP-C partly changed the subcellular localization of Bcl-x L and Bcl-2 to the ER. Consistent with their binding speci®city, RTN-x S decreased the anti-apoptotic activity of both Bcl-x L and Bcl-2, while NSP-C only reduced that of Bcl-x L and not that of Bcl-2. Because Bcl-x L and Bcl-2 are thought to exert their anti-apoptotic activity mainly through an eect on the mitochondria (reviewed by Green and Reed, 1998; Tsujimoto and Shimizu, 2000) , one mechanism for impairment of the antiapoptotic activity of Bcl-2 family proteins by RTN-x S and NSP-C is likely to involve their change in subcellular localization from the mitochondria to the ER.
Sequence alignment analysis showed that RTN-x S and NSP-C were not members of the Bcl-2 family. Among Bcl-2-interacting proteins that do not belong to the Bcl-2 family (reviewed by Tsujimoto, 1998) , only 14-3-3 is well documented to regulate the subcellular localization of Bad, a pro-apoptotic Bcl-2 family member (Zha et al., 1996) . Protein 14-3-3 binds to Bad that has been phosphorylated, and prevents its translocation to the mitochondria, consequently preventing apoptosis mediated by Bad (Zha et al., 1996) . On the other hand, none of the Bcl-2-interacting proteins from outside the Bcl-2 family have been reported to be involved in the subcellular translocation of Bcl-x L and Bcl-2. RTN-x S and NSP-C speci®cally interact with anti-apoptotic Bcl-2 family proteins and not with pro-apoptotic family members, for example Bax (unpublished observations), indicating that RTN-x S and NSP-C are the ®rst non-Bcl-2 family proteins that have been found to regulate the subcellular localization of anti-apoptotic Bcl-2 family members.
It was reported that anti-apoptotic Bcl-2 family proteins changed their subcellular localization upon apoptotic stimulation. For example, some of the Bcl-2 on the ER moves to the mitochondria when CEM cells are treated with TNF-a (Jia et al., 1999) . Bcl-x L , which is recovered in both the soluble fraction and the membrane pellet under unstimulated conditions, becomes predominantly membrane-associated within 2 h after the induction of apoptosis by dexamethasone or g-irradiation (Hsu et al., 1997) . Translocation of Bcl-x L and Bcl-2 to the mitochondria upon apoptotic stimulation could be involved in the rescue of mitochondrial dysfunction and the prevention of apoptosis, because retention of these proteins on the ER by binding to overexpressed RTN-x S and NSP-C blocked their anti-apoptotic activity. Thus, localization of anti-apoptotic Bcl-2 proteins to the mitochondria might be regulated by their interaction with RTN-x S , NSP-C, and other RTN family proteins.
Although several studies have shown that Bcl-2 is localized to the ER and nuclear envelope in addition to the mitochondrial membrane (Krajewski et al., Translocation of Bcl-x L and Bcl-2 to ER by RTN-x S S Tagami et al 1993; Akao et al., 1994) , the role of Bcl-2 in the ER has remained unclear when compared with that in the mitochondria. As shown in Figure 7 , reduction of the anti-apoptotic activity of Bcl-x L and Bcl-2 by RTN-x S or that of Bcl-x L by NSP-C was stronger in TM-induced apoptosis than STS-induced one, suggesting that the complex of Bcl-x L or Bcl-2 with RTN-x S or NSP-C formed on ER, or the overexpression of RTN-x S and NSP-C itself might have some role in inducing apoptosis under ER stress. Recent studies have suggested that ER stress triggers the formation of unfolded proteins and thus leads to the induction of several heat shock-related proteins through phosphorylation of an ER protein, IRE1 (reviewed by Kaufman, 1999) . Several candidate molecules have been suggested to be released from the ER by ER stress. Such factors might also activate initiator caspases, such as caspase-12, which was recently shown to be essential for apoptosis induced by ER stress (Nakagawa et al., 2000) . It is possible that Bcl-x L and Bcl-2 form a complex with these caspases and some unknown adopter molecules, like the apoptosome found on the mitochondrial membrane (Pan et al., 1998; Hu et al., 1998) . Bap31, which interacts with Bcl-x L and Bcl-2 and is cleaved by caspase-8 (Ng et al., 1997) , is one candidate for such an adopter. It was also reported that Bcl-2 interacts with the sarcoplasmic Ca
2+
ATPase pump (Kuo et al., 1998) , and that Bcl-x L and Bcl-2 can regulate the release of calcium from intracellular stores, which are primarily located in the ER (Bay et al., 1993; Lam et al., 1994; He et al., 1997) . RTN-x S might interact with Bcl-x L and Bcl-2 to prevent the formation of a Bcl-2-containing anti-apoptotic complex on the ER and/or to facilitate the release of apoptotic factors. RTN family proteins, including RTN-x S and NSP-C, seem to be a useful tool to investigate the eects of Bcl-x L and Bcl-2 on the ER. Recently, it was reported that the product of the human cDNA clone KIAA0886 (designated Nogo-A, which is the same as RTN-x L ) and its rat homologue could be localized on the surface of oligodendrocytes or myelin where it inhibited neurite outgrowth (GrandPre et al., 2000; Chen et al., 2000) , although the majority of Nogo-A was localized on the ER. It is of interest to note that neuronal overexpression of Bcl-2 promotes neurite outgrowth and axonal regeneration both in vivo (Chen et al., 1997) and in vitro (Sato et al., 1994; Oh et al., 1996) . Although myelin-associated Nogo-A acts on neurons (GrandPre et al., 2000; Chen et al., 2000) , it is conceivable that neurite outgrowth could be regulated by an intrinsic neuronal Nogo-A/RTN-x L . Therefore, it is possible that Bcl-x L and Bcl-2 promote neurite outgrowth through inhibition of the cell surface expression of Nogo-A/RTN-x L by sequestration to the ER. Taken together with the recent suggestion that ER stress is involved in some neurodegenerative diseases such as Alzheimer's disease, further studies on RTN and Bcl-x L /Bcl-2 may provide some insights not only into the eects of Bcl-x L /Bcl-2 on the ER but also into neurodegenerative diseases and axonal regeneration. Figure 4 and analysed by Western blotting using anti-Bcl-x L and anti-Bcl-2 mAbs. A fraction (%; mean+s.d.) of Bcl-x L or Bcl-2 recovered in three dierent fractions derived from low speed supernatant (a mitochondria-enriched fraction, a microsomal fraction, and a cytosolic fraction) was calculated from three independent experiments, and shown under each panel. The translocation of Bcl-x L to the ER by RTN-x S or NSP-C and that of Bcl-2 by RTN-x S were signi®cant (**P50.02), while that of Bcl-2 by NSP-C was not signi®cant (#P40.2). Fractionated lysates from Bcl-x L -expressing cells were also subjected to Western blotting using anti-VDAC mAb (third panels in a, b, and c), or an antipresenilin-1 pAb (bottom panels in a, b, and c). 
Materials and methods
Plasmid construction
pBTM116-Bcl-x L was constructed for yeast two-hybrid screening to produce Bcl-x L fused to the DNA-binding domain of LexA. pBTM116-Bcl-2 and pBTM116-Rad51 were described previously (Iwahashi et al., 1997) . The genes for HA-RTN-x S and HA-NSP-C were constructed so that the HA epitope were fused to the second codon of RTN-x S and NSP-C using PCR primers. HA-RTN-x S , HA-NSP-C, human Bcl-x L , and human Bcl-2 cDNAs were cloned in the vector pCAGGS bearing a chicken b-actin promoter and CMV enhancer for expression in mammalian cells.
Antibodies
Anti-HA mAb (clone 12CA5), anti-HA antiserum, anti-Bclx L mAb (#44), anti-Bcl-2 mAb (6C8), anti-VDAC mAb (31HL), and Anti-Grp78 (Bip) mAb (10C3) were purchased from Boehringer Mannheim, Medical and Biochemical Laboratory (MBL, Japan), Transduction Labs, Pharmingen, Calbiochem, and StressGen, respectively. Anti-Bcl-x L pAb (S-18) and anti-Bcl-2 pAb (N-19) were obtained from Santa Cruz Biotechnology. Anti-presenilin-1 pAb was kindly provided by Dr Takashi Kudo (Osaka University). For use in this study, anti-RTN-x S pAb was raised by immunizing rabbits with the peptide 
Yeast two-hybrid screening
The L40 yeast strain transfected with pBTM116-Bcl-x L was used to screen oligo (dT) and/or random-primed human fetal and adult brain cDNA fusion libraries in a Gal4-activating domain vector (pGAD10, Clontech). Details of the methods employed were described previously (Iwahashi et al., 1997) .
cDNA cloning of RTN-x
Searching the EST database, we identi®ed THC 167126 and THC 161296 carrying information of 5'-neighboring region of 4-20 s clone. To obtain the cDNA for the entire coding region of RTN-x, the human fetal brain 5' STRETCH cDNA After culture for 36 h, cells were treated with 1.5 mg/ml of TM (a and b) or 1 mM of STS (c and d) and were examined for apoptosis at the indicated times as described in Materials and methods. Results were expressed as mean+s.d. calculated from three independent experiments (***P50.003, **P50.01, *P50.03, all of which were regarded as signi®cant, while #P40.07 as not signi®cant)
Translocation of Bcl-x L and Bcl-2 to ER by RTN-x S S Tagami et al library (Clontech) was screened by the plaque hybridization procedure using the PCR-generated 713 bp fragment (from the ®rst base pair of THC 161296 to the 295th bp of the THC 167126) as a probe. Initially, eight independent clones were obtained from 1610 6 clones. Since we could not ®nd an inframe stop codon in upstream region from candidate initiation codons in these clones, the screening was done again using the clone with the longest cDNA as a probe, and we obtained four independent clones from 1610 6 clones with an in-frame stop codon at 126 bp upstream of the putative initiation site in the cDNA. The sequence of the 5' region was con®rmed by sequencing the RT ± PCR fragment obtained using human brain mRNA as a template. The resultant cDNA had a 3576 bp open reading frame, and was named RTN-x L . We also obtained six independent clones that lacked base pairs 556 to 3013 of the longer form, giving an 1119 bp open reading frame, which was named RTN-x S .
Northern blotting
Human poly(A) + RNA tissue blots (Clontech) were hybridized according to the manufacturer's instructions using 32 P-labeled DNA fragments corresponding to amino acid residues 45 to 204 of RTN-x S as a probe. The blot was ®nally washed with 16SSC containing 0.1% SDS for 30 min at 658C.
Immunoprecipitation and Western blotting
COS-7 cells (2 ± 5610 6 ) were transfected with 3 mg each of the indicated plasmids using LipofectAMINE TM (Gibco BRL). Immunoprecipitation was performed as described elsewhere (Iwahashi et al., 1997) . In some experiments, immunoprecipitation was carried out using Jurkat cells treated with a cleavable chemical cross-linker DTBP (Dimethyl 3,3'-dithiobispropionimidate-2HCl) as described elsewhere (Narita et al., 1998) . Immune complexes were subjected to Western blot analysis using speci®c antibodies and an enhanced chemiluminescence system (Amersham).
Subcellular fractionation
D98/AH2 cells (2 ± 5610 6 ), derived from HeLa cells, were transiently transfected with 3 mg each of the indicated plasmids using LipofectAMINE 2000 TM (Gibco BRL). After culture for 36 h, the cells were collected, washed with PBS, and suspended in a hypotonic solution (10 mM HEPES ± NaOH, pH 7.4, 10 mM MgCl 2 , 42 mM KCl) for 5 min on ice. Then the cells were passed through a 30-gauge needle once and centrifuged at 600 g for 10 min to collect a crude nuclear pellet, which contained both nuclei and residual undisrupted cells. The supernatant was centrifuged at 7000 g for 10 min to yield a mitochondria-enriched pellet. This supernatant was further centrifuged at 100 000 g for 90 min to yield a microsomal pellet and a cytosolic fraction. All of the pellets were dissolved in 26PBS, 1% NP40, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate. To obtain a nuclear fraction without the outer membrane, cells were suspended in the hypotonic solution with 0.5% NP40 and were centrifuged at 12 000 g for 10 min. Three independent experiments were performed in order to examine the translocation of Bcl-x L and Bcl-2. A fraction (%, mean+s.d.) of Bcl-x L or Bcl-2 in three dierent fractions derived from low speed supernatant (a mitochondrial-enriched fraction, a microsomal fraction, and a cytosolic fraction) was calculated by densitometric analysis using Science Lab 98 Image Gauge Version 3.1 (Fuji Film). Student's t-test was used to evaluate signi®cance in dierences between amounts of Bcl-x L and Bcl-2 recovered in each fraction and those in respective control fraction. Less than 5% of probability was regarded as signi®cant dierence in the present experiments.
Immunocytochemistry COS-7 cells were plated at 20% con¯uence onto 33 mm poly-L-lysine coated dishes. Cells were transiently transfected with a total of 0.5 mg of indicated plasmids. Thirty-six hours after transfection, cells were incubated in 50 ng/ml of Mito Tracker Orange, CMTM-Ros (Molecular Probes) to stain the mitochondria for 10 min. Cells with or without Mito Tracker treatment were washed with PBS, ®xed in 4% paraformaldehyde, and permeabilized in 0.5% Triton X-100. Immunostaining was performed using anti-HA mAb or antiBcl-x L mAb, followed by Alexa 488-conjugated anti-mouse IgG antibody (Molecular Probes). In some cases, cells were subsequently stained with anti-Bip mAb and Alexa 543-conjugated anti-mouse IgG antibody. Cells were then examined with a confocal¯uorescence microscope (Zeiss).
Apoptosis assay
Stable transformants of D98/AH2 cells expressing human Bcl-x L were generated by electroporation. Stable transformants of D98/AH2 cells expressing human Bcl-2 were described previously (Iwahashi et al., 1997) . Cells (2 ± 3610 5 ) were transiently transfected with indicated plasmids (1 mg) together with the reporter plasmid pEGFP (green uorescent protein)-F (0.1 mg; Clontech) using LipofectA-MINE 2000
TM
. After culture for 36 h, cells were treated with 1.5 mg/ml of tunicamycin (Sigma) or 1 mM of staurosporine (Wako Biochemicals, Japan) for the indicated periods, stained with 10 mM Hoechst 33342 (Calbiochem), and examined under a¯uorescent microscope. At least 200 GFP-positive cells were examined to determine whether they were viable or apoptotic from their nuclear morphology. The mean+s.d. of the ratio of apoptotic cells was calculated from three independent experiments. Student's t-test was used to evaluate the eects of RTN-x S and NSP-C on Bcl-x L and Bcl-2 expressing cells.
Abbreviations ER, endoplasmic reticulum; mAb, monoclonal antibody; pAb, polyclonal antibody; TM, tunicamycin; STS, staurosporine; VDAC, voltage-dependent anion channel
